Amgen Inc. (AMGN) discovers, develops, manufactures, markets, and delivers human therapeutics worldwide. The company focuses on a wide range of areas, such as inflammation, oncology, cardiovascular disease, bone health, and neuroscience. It serves healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies.
The company has been delivering solid financial performance by serving patients globally with its diverse and growing portfolio of marketed medicines in large therapeutic categories. Its products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; and KYPROLIS to treat relapsed multiple myeloma.
